Why Testosterone for Women Is So Controversial
Testosterone for Women
Introduction
If this is your first time hearing this, you’re not alone—testosterone remains one of the most misunderstood and emotionally charged hormones in women’s health. For decades, the conversation around women’s hormones has focused almost entirely on estrogen and progesterone, while testosterone has been quietly pushed to the sidelines or treated as something women “shouldn’t need.”
That silence has consequences.
Many women experience symptoms that don’t neatly fit into traditional menopause conversations—changes in libido, energy, mood, motivation, pelvic comfort, or overall sense of self—yet are repeatedly told their hormones are “normal.” In reality, what often goes unmeasured, unaddressed, or dismissed is testosterone.
Testosterone in women is controversial not because the science is absent, but because the topic sits at the intersection of outdated medical training, cultural discomfort, regulatory gaps, and fear-based narratives. Understanding why this hormone became controversial is the first step toward having a more informed, responsible, and patient-centered conversation.
Testosterone Is Not a “Male Hormone”
One of the biggest sources of confusion is the persistent myth that testosterone belongs to men, while estrogen belongs to women. Biologically, this framing is incorrect.
Women produce testosterone throughout their lives, primarily from the ovaries and adrenal glands. While absolute levels are lower than in men, testosterone plays meaningful roles in multiple systems, including sexual health, musculoskeletal integrity, urogenital tissues, and brain signaling. Dr Peter Attia
When hormone levels are normalized to comparable units, many women are surprised to learn that testosterone is not a minor background hormone—it is present in significant quantities and interacts closely with estrogen and progesterone.
Despite this, most women are never educated about testosterone’s role, and many clinicians receive little formal training on how to evaluate or discuss it.
Testosterone Declines With Age—Not Just Menopause
Another reason testosterone remains controversial is the misconception that it is strictly a menopause-related issue.
Testosterone levels in women begin to decline gradually starting in early adulthood, often becoming noticeable in the 30s and 40s—well before menopause. This decline is age-related and does not necessarily track with menstrual regularity.
This is why statements like “your periods are normal, so your hormones are fine” can be misleading. Regular cycles do not reflect testosterone levels, and standard hormone panels often omit it entirely.
Personalized hormone support, weight loss, and aesthetic care for people ready to feel like themselves again.
Because testosterone does not follow the same cyclical patterns as estrogen and progesterone, it is frequently overlooked, leaving a gap in how women’s symptoms are evaluated.
Birth Control and the Lifelong Testosterone Gap
Hormonal birth control adds another layer to the controversy.
Combined oral contraceptives suppress ovarian hormone production and replace estrogen and progestin synthetically—but they do not replace testosterone. Over time, this suppression can contribute to lower circulating testosterone levels and reduced bioavailability.
For some women, symptoms that emerge during or after long-term contraceptive use are not immediately recognized as hormone-related, especially when estrogen and progesterone appear “within range.”
This creates a life-course issue where testosterone is quietly diminished long before menopause ever begins, yet rarely addressed in routine care.
What the Evidence Actually Supports
Globally, one area where medical consensus does exist is the use of testosterone therapy for postmenopausal women with hypoactive sexual desire disorder (HSDD). Multiple international position statements acknowledge that appropriately dosed testosterone can improve sexual desire in this specific population.
That said, controversy remains because:
-
There is no FDA-approved testosterone formulation specifically for women in the United States
-
Much of the available data focuses on postmenopausal women, with less research in perimenopause
-
Prescribing requires off-label use, which many clinicians are uncomfortable with
-
Training on dosing, monitoring, and risk discussion is inconsistent
This does not mean testosterone is unsafe—it means the medical system has not kept pace with patient needs or emerging evidence.
For additional context, expert discussions such as those summarized in long-form clinical conversations on women’s sexual health highlight how education gaps, not data absence, drive much of the hesitation.
Fear, Stigma, and Misunderstood Side Effects
Testosterone carries cultural baggage.
For many women, the word itself conjures fears of excessive hair growth, voice changes, acne, or masculinization. While these effects are possible at supraphysiologic doses, they are uncommon when testosterone is prescribed conservatively and monitored appropriately.
In clinical practice, the most commonly discussed side effects at low doses include mild acne or increased hair growth, which are typically dose-dependent and reversible. More serious androgenic effects are associated with high, unregulated dosing—particularly pellet therapy—where adjustments cannot be easily made.
This distinction is often lost in public discourse, fueling fear rather than informed decision-making.
Why Pellets Intensify the Controversy
Delivery method matters.
Pellet therapy introduces testosterone at levels that may exceed physiologic ranges and cannot be quickly adjusted or discontinued. For clinicians who prioritize control, reversibility, and safety, this raises valid concerns.
Topical formulations allow for:
-
Lower, adjustable dosing
-
Gradual titration
-
Ongoing symptom and lab monitoring
The controversy is less about testosterone itself and more about how it is used.
The “Missing Piece” Experience
When testosterone is discussed as part of a broader, balanced hormone conversation—alongside estrogen and progesterone—many women describe a shift that is difficult to quantify on lab paper alone.
Common reflections include:
-
Feeling more like themselves again
-
Improved motivation or mental clarity
-
Greater sexual comfort or interest
-
A sense that something long ignored was finally addressed
These experiences do not guarantee outcomes, and they are not universal—but they are consistent enough to warrant thoughtful, individualized discussion rather than dismissal.
Why This Conversation Belongs in Responsible Medicine
Testosterone for women is controversial because medicine has historically avoided nuance in favor of simplicity. Women’s health is not simple.
At My V Clinic, discussions around hormones are grounded in:
-
Education, not pressure
-
Evidence, not trends
-
Monitoring, not guesswork
-
Options, not assumptions
Testosterone is not appropriate for everyone. But avoiding the conversation altogether serves no one.
Related Reading
- What’s Up With My Libido? Understanding Low Libido in Women
- Perimenopause and Menopause Hormones: What Changes and Why It Matters
- Hormone Imbalance Signs You Shouldn’t Ignore